Results · Apr-Jun 2026
Jeevan Scientific Technology Q1 FY27 results
Sales grew 108% to ₹18.3 crore from ₹8.8 crore in Apr-Jun 2025.
Operating profit was ₹3 crore, an operating margin of 16.2% (up 36.4 points from a year ago).
Net profit turned positive: ₹0.87 crore against a loss of ₹3.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −14%, net profit −53%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 18.3 | 8.8 | +108% |
| Operating profit (EBITDA) | 3.0 | -1.8 | n/m |
| Operating margin | 16.2% | −20.3% | +36.4 pts |
| Net profit | 0.9 | -3.2 | turns positive |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.